È necessario avere un abbonamento a JoVE per visualizzare questo. Accedi o inizia la tua prova gratuita.
1Cardiovascular Research Institute for Intractable Disease, College of Medicine,The Catholic University of Korea, 2Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine,The Catholic University of Korea, 3Division of Cardiology, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine,The Catholic University of Korea
Capitoli
- 00:05Introduction
- 01:49Preparation of MSCs and Injectable Gelatin Hydrogels
- 03:38In Situ MSC-loading and Three-dimensional in Vitro Culture
- 04:29Induction of Myocardial Infarction in Mice
- 05:44Intramyocardial Transplantation of MSC-loading GH Hydrogels
- 06:37Results: Improving Stem Cell Retention and Engraftment with Injectable Hydrogels
- 08:31Conclusion
Die Stammzelltherapie hat sich als effiziente Strategie zur Reparatur von verletztem Herzgewebe nach einem Myokardinfarkt herauskristallisiert. Wir bieten eine optimale In-vivo-Anwendung für die Stammzelltransplantation mit gelatinenhydrogelen, die enzymatisch vernetzt werden können.
Tags
Mesenchymal Stem CellsMSCsInjectable HydrogelsIntramyocardial TransplantationMyocardial InfarctionMurine ModelCell RetentionCell SurvivalGrowth FactorsGenetic MaterialsDrugsIn Vitro ExperimentIn Vivo ExperimentCell CultureCell SuspensionTrypsinTrypan BlueCell CountingGH Conjugate SolutionHydrogen PeroxideDual Syringe
